Semaglutide targets these pathways through medication, and a well-balanced microbiome supports it
And that distinction matters more than most people realize
Numerous pro-fibrotic mediators, such as TGF-, TNF-, and FGF, exhibit PDGF-associated pro-fibrotic activity (Chaudhary et al., 2007)
If you have a history of weight cycling, consider this when planning your GLP-1 treatment duration
48 As an add-on to insulin with or without metformin (PIONEER 8), oral semaglutide (at doses of 3, 7 and 14 mg) was shown to be associated with superior HbA1c and body weight reductions versus placebo as early as at week 26 and achieved further reduction in insulin need (except dose 3 mg) at week 52, without significantly increasing the rate of hypoglycemia
Tirzepatide targets GLP-1 and GIP receptors to lower blood sugar, reduce hunger cues, and slow digestion so you feel full faster